Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / S&P SMLCP INDL
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
379K
-
Shares change
-
+2.27K
-
Total reported value, excl. options
-
$30.2M
-
Value change
-
+$521K
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$79.74
Significant Holders of INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL (PSCI) as of Q4 2020
19 filings reported holding PSCI - INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL as of Q4 2020.
INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL (PSCI) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 379K shares
.
Largest 10 shareholders include MORGAN STANLEY (111K shares), UBS Group AG (104K shares), BANK OF AMERICA CORP /DE/ (96.4K shares), SALEM INVESTMENT COUNSELORS INC (27.7K shares), WELLS FARGO & COMPANY/MN (13.5K shares), CITADEL ADVISORS LLC (8.35K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (6.05K shares), ROYAL BANK OF CANADA (4.61K shares), RAYMOND JAMES & ASSOCIATES (2.62K shares), and US BANCORP \DE\ (2K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.